What is the address of Laboratoria Bota?

The registered office of Laboratoria Bota is located at Stadionlaan 12, 9800 Deinze.

Is Laboratoria Bota still active?

Yes. According to the CBE (30 October 2026) Laboratoria Bota is active, legal situation “Normale toestand”, started on 1 January 1968.

Is Laboratoria Bota registered on Peppol?

Yes, Laboratoria Bota is registered on the Peppol network with ID 0208:0401005027.

What is the enterprise number of Laboratoria Bota?

The enterprise number of Laboratoria Bota is BE0401005027.

When was Laboratoria Bota founded?

Laboratoria Bota was founded on 1 January 1968.

Who are the directors of Laboratoria Bota?

According to the 2025 annual accounts, the directors of Laboratoria Bota are: Philippe Moerkens, All Braces Company NV.

Is Laboratoria Bota a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1968; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Laboratoria Bota make in 2025?

Laboratoria Bota recorded a loss after taxes of € 677,685 in financial year 2025.

What is the revenue of Laboratoria Bota?

As a small company, Laboratoria Bota is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,773,855.

How much does an employee at Laboratoria Bota earn?

The average wage cost per full-time employee at Laboratoria Bota was € 54,000 in 2025: staff costs of € 2.2 million for 40.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Laboratoria Bota have?

According to the 2025 annual accounts, Laboratoria Bota has 40.1 full-time equivalents (FTE).

Does Laboratoria Bota have a website?

Yes, Laboratoria Bota has a website at bota.be.

Laboratoria Bota (Public Limited) - Deinze - BE0401005027

Q: What does Laboratoria Bota do?

Laboratoria Bota is registered with the CBE as active in: Vervaardiging van overige farmaceutische producten. Public Limited, started on 1 January 1968, 1 establishment.

Dossier Laboratoria Bota, printed on 30 October 2026 from databakkes.be/en/0401005027/laboratoria-bota. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 52 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Laboratoria Bota from Deinze, company number BE0401005027, closed financial year 2025 with a result of € -677,685 after tax. For that financial year Laboratoria Bota recorded a gross margin of € 1.8 million and equity of € 692,848. Compared with financial year 2024, the result moved from € 27,194 to € -677,685. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.

What it is worth Healthy

€ 692,848

▼ 49% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -677,685

▼ still € 27,194 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 195,326

▼ 42% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 630,848.

People and assets in 2025

Full-time equivalents

40.1

▲ 1.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 2.2 million

▲ 14% vs 2024

€ 54,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 95,838

▼ 41% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.9 million

▲ 107% vs 2024

€ 160,923 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 447,829

▼ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 324,950

▼ 7% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 2,039,674 Gross margin 2022: € 2,039,674 First fiscal year in the series	€ 2,322,029 Gross margin 2023: € 2,322,029 ▲ 14% vs 2022 (€ 2,039,674) Favourable step	€ 2,228,085 Gross margin 2024: € 2,228,085 ▼ 4% vs 2023 (€ 2,322,029) Unfavourable step	€ 1,773,855 Gross margin 2025: € 1,773,855 ▼ 20% vs 2024 (€ 2,228,085) Unfavourable step	▼ 20%
Profit after taxes	€ -12,293 Profit after taxes 2022: € -12,293 First fiscal year in the series	€ 40,395 Profit after taxes 2023: € 40,395 ▲ € 52,688 vs 2022 (€ -12,293) Favourable step	€ 27,194 Profit after taxes 2024: € 27,194 ▼ 33% vs 2023 (€ 40,395) Unfavourable step	€ -677,685 Profit after taxes 2025: € -677,685 ▼ € 704,878 vs 2024 (€ 27,194) Unfavourable step	▼ € 704,878
Equity	€ 1,302,944 Equity 2022: € 1,302,944 First fiscal year in the series	€ 1,343,339 Equity 2023: € 1,343,339 ▲ 3% vs 2022 (€ 1,302,944) Favourable step	€ 1,370,533 Equity 2024: € 1,370,533 ▲ 2% vs 2023 (€ 1,343,339) Favourable step	€ 692,848 Equity 2025: € 692,848 ▼ 49% vs 2024 (€ 1,370,533) Unfavourable step	▼ 49%
Total debts	€ 1,764,539 Total debts 2022: € 1,764,539 First fiscal year in the series	€ 2,558,854 Total debts 2023: € 2,558,854 ▲ 45% vs 2022 (€ 1,764,539) Unfavourable step	€ 2,750,100 Total debts 2024: € 2,750,100 ▲ 7% vs 2023 (€ 2,558,854) Unfavourable step	€ 2,930,337 Total debts 2025: € 2,930,337 ▲ 7% vs 2024 (€ 2,750,100) Unfavourable step	▲ 7%
Cash	€ 162,240 Cash 2022: € 162,240 First fiscal year in the series	€ 297,549 Cash 2023: € 297,549 ▲ 83% vs 2022 (€ 162,240) Favourable step	€ 335,222 Cash 2024: € 335,222 ▲ 13% vs 2023 (€ 297,549) Favourable step	€ 195,326 Cash 2025: € 195,326 ▼ 42% vs 2024 (€ 335,222) Unfavourable step	▼ 42%
Land & buildings	€ 111,417 Land & buildings 2022: € 111,417 First fiscal year in the series	€ 90,928 Land & buildings 2023: € 90,928 ▼ 18% vs 2022 (€ 111,417) Unchanged	€ 78,412 Land & buildings 2024: € 78,412 ▼ 14% vs 2023 (€ 90,928) Unchanged	€ 73,685 Land & buildings 2025: € 73,685 ▼ 6% vs 2024 (€ 78,412) Unchanged	▼ 6%
Retained profit	€ 1,240,944 Retained profit 2022: € 1,240,944 First fiscal year in the series	€ 1,281,339 Retained profit 2023: € 1,281,339 ▲ 3% vs 2022 (€ 1,240,944) Favourable step	€ 1,308,533 Retained profit 2024: € 1,308,533 ▲ 2% vs 2023 (€ 1,281,339) Favourable step	€ 630,848 Retained profit 2025: € 630,848 ▼ 52% vs 2024 (€ 1,308,533) Unfavourable step	▼ 52%
Bank debt	€ 467,816 Bank debt 2022: € 467,816 First fiscal year in the series	€ 642,850 Bank debt 2023: € 642,850 ▲ 37% vs 2022 (€ 467,816) Unfavourable step	€ 909,639 Bank debt 2024: € 909,639 ▲ 42% vs 2023 (€ 642,850) Unfavourable step	€ 1,881,540 Bank debt 2025: € 1,881,540 ▲ 107% vs 2024 (€ 909,639) Unfavourable step	▲ 107%
Balance sheet total	€ 3,067,483 Balance sheet total 2022: € 3,067,483 First fiscal year in the series	€ 3,902,194 Balance sheet total 2023: € 3,902,194 ▲ 27% vs 2022 (€ 3,067,483) Unchanged	€ 4,120,633 Balance sheet total 2024: € 4,120,633 ▲ 6% vs 2023 (€ 3,902,194) Unchanged	€ 3,623,185 Balance sheet total 2025: € 3,623,185 ▼ 12% vs 2024 (€ 4,120,633) Unchanged	▼ 12%
Employees (FTE)	39.2 Employees (FTE) 2022: 39.2 First fiscal year in the series	41.1 Employees (FTE) 2023: 41.1 ▲ 1.9 vs 2022 (39.2) Unchanged	38.3 Employees (FTE) 2024: 38.3 ▼ 2.8 vs 2023 (41.1) Unchanged	40.1 Employees (FTE) 2025: 40.1 ▲ 1.8 vs 2024 (38.3) Unchanged	▲ 1.8

Key figures of Laboratoria Bota, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Laboratoria Bota?

What happened at Laboratoria Bota in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Philippe Moerkens stepped down as director. NBB
2028 All Braces Company NV stepped down as director. NBB
Jul 16, 2026 New annual accounts for financial year 2025: loss of € 677,685 (▼ € 704,878 vs 2024). Source: NBB ↗
2022 Philippe Moerkens became a director. NBB
2022 All Braces Company NV became a director. NBB
Jan 1, 1968 Start of the company according to the CBE. KBO
Nov 1, 1945 New establishment in Deinze. KBO

In short

From € 12,293 loss in 2022 to € 677,685 loss in 2025.

Paid € 45,195 in corporate taxes since 2022.

Best year ever: 2023, with € 40,395 profit.

On average € 44,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ALL BRACES COMPANY 100%

The stake of ALL BRACES COMPANY comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Laboratoria Bota

The shares are held by ALL BRACES COMPANY (100%).

Directors

According to the 2025 annual accounts

Philippe Moerkens

Managing director

since 2022 · until 2028

All Braces Company NV

Director · represented by Annick Tavernier

since 2022 · until 2028

Shareholders

ALL BRACES COMPANY

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Stadionlaan 12

9800 Deinze

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

BOTA GROEP

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS bota.be

Technologies

Contact Form 7Google AnalyticsNginxPHPWPMLWooCommerceWordPressWordfenceYoast SEOjQuery

Certifications & Partners

RIZIV

Hosting & Email

Email provider

Microsoft 365

Hosting

COMBELL-AS, BE

Website info

HTTPS Ja

Languages DE_DE, EN_GB, FR_FR, NL

Features

Webshop

Security

✓ HTTPS

✓ SPF

✓ DMARC

Network

✓ IPv6

Details

Company number

0401.005.027

VAT number

BE 0401.005.027

Registered office

Stadionlaan 12, 9800 Deinze

Names & denominations

Laboratoria Bota

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

1 January 1968

Peppol

Active · Active since 1 Jan 2001

Contact

bota.be

Activities · NACE

Vervaardiging van overige farmaceutische producten

Vervaardiging van overige farmaceutische preparaten

Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Laboratoria Bota

Warning lights

Financials

What happened to Laboratoria Bota?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Certifications & Partners

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions